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Glutamate is the most common neurotransmitter in the brain, but excessive activation of glutamate 
receptors results in neuronal dysfunction and death, a process called excitotoxicity. Excitatory 
amino acid transporter (EAAT) proteins are responsible for reuptake of glutamate from the 
synapse, thus keeping extracellular glutamate levels low and preventing injury. EAAT1/GLAST 
and EAAT2/GLT-1 are prevalent in the brain and primarily expressed in glial cells. Previous work 
by the Kirby lab and others demonstrates that neural stem and progenitor cells (NSPCs) in the 
adult hippocampus also express EAAT1 and EAAT2, though the function of EAATs in NSPCs is 
poorly understood. Given the important role of EAATs in protection from excitotoxic injury, we 
studied EAAT expression patterns in mice given kainic acid (KA), which causes excessive 
glutamate release and seizures. Previous work in the Kirby lab shows that EAAT1 and EAAT2 
mRNA decline in the dentate gyrus (DG) subregion of the hippocampus beginning 1 day after KA 
injury. However, it is unknown which cell populations are driving this tissue-level change. In the 
present study, we used EAAT2-GFP and EAAT1-dsRed transcriptional reporter mice to examine 
EAAT2 and EAAT1 transcription in the DG after KA injury. We quantified the mean GFP 
fluorescence intensity (FI) in the whole dentate gyrus, a region occupied by EAAT2-expressing 
astrocytes and NSPCs, and found no difference between KA-injured mice and controls 1,3  and 7 
day post-injection. Similarly, GFP FI in the subgranular zone, a region predominantly occupied by 
NSPCs, did not differ from controls. We also quantified GFAP% area to assess astrogliosis and 
found a trend towards increased GFAP% area, which did not reach significance (p = 0.149), 1 day 
after injury.  This is consistent with previous results in wild-type mice demonstrating a non-
significant trend toward astrogliosis 1 day post-injury and significant astrogliosis beginning 3 days 
after injury. There was no significant difference in EAAT transcription in both EAAT1-dsRed and 
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EAAT2-GFP mice 3 and 7 days after injury, time points previously found to coincide with 
astrogliosis. Future analysis will examine these cell specific changes in fluorescent reporter 
expression using a combination of protein marker expression, cell morphology, and anatomical 
location to identify  astrocytes and neural stem cells. We expect these studies to increase our 
understanding of whether reduced EAAT expression following KA injury occurs globally or in 
specific cell populations. Our findings could help refine treatment strategies for brain disorders 
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Glutamate is the main excitatory neurotransmitter in the brain, and prolonged activation of 
glutamate receptors results in neuronal damage known as excitotoxicity. Glutamate transporters 
are responsible for uptake of glutamate from the extracellular fluid in the brain and thus avoid 
unnecessary activation of glutamate receptors (Zhou et al. 2014). The  glutamate clearance from 
the synapse maintains homeostasis by keeping the  high temporal and  spatial fidelity of the 
transmission through the use of glutamate transporters (Hanson et al. 2015).  
The glutamate transporter gene family has five excitatory amino acid transporter (EAAT) 
members (EAAT1–EAAT5) and these transporters are expressed in the brain in highly specific 
regional and cell-type patterns (Kavanaugh 2008). Expression of both EAAT1 and EAAT2 is 
prominent in the dentate gyrus (DG) of the hippocampus, a brain region important for cognition 
(O’Donovan et al 2017). These two transporters, EAAT1 (GLAST) and EAAT2 (GLT-1), are 
substantially expressed by the astrocytic plasma membrane, providing these cells with an 
enormous capacity for glutamate uptake (Schousboe 2005).  
Previous studies suggest that astrocyte-expressed EAAT2 is responsible for greater than 
90% of glutamate transport and is the predominant glutamate transporter in the brain  (Kim et al. 
2011). Furthermore, An additional EAAT-expressing population unique to the adult DG are adult 
neural stem and progenitor cells (NSPCs). Preliminary data from my lab shows that NSPCs express 
both EAAT1 and EAAT2, but not other EAATs. But, it is not clear whether the EAAT expression 
by the cells (glial, astrocytes and NSPCs) occurs globally or it is cell specific. It would be 
interesting to look at how the expression changes from one cell population to other in the 
hippocampus after Kainic Acid (KA).  
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Kainic acid is often used as a model of excitotoxicity  and causes uncontrolled release of 
glutamate(Wang et al. 2005). When injected, KA binds to kainate receptors and results in an initial 
latent period followed by the onset of the seizures  (Hubbard et al. 2016). The seizure activity is 
monitored by observing the mice using a well recognized behavioral response following KA 
injection. This includes mice showing “staring” spells, head nodding, and facial movements in the 
first 30 mins. After one hour,  the animal starts recurrent limbic motor seizures, forepaw tremors, 
rearing and loss of balance. (Zhang et al. 2011). Prolonged seizures to KA adversely impacts  the 
hippocampus and results in neurotoxicity due to  excess glutamatergic stimulation  and thus, causes 
neuronal damage in hippocampus(Zhang et al. 2011).  
My research focuses on EAAT expression by astrocytes and NSPCs following injury. I 
specifically analyzed the subgranular zone (SGZ) of the DG and the entire DG (combined hilus, 
SGZ, and granule cell layer) based on the location of these cells to detect how they change in the 
expression. I used transcriptional reporter mice for both EAAT2-GFP and EAAT1-dsRed to 
examine EAAT2 and EAAT1 transcription in the DG after KA injury (Regan et. al 2007). We 
looked at the expression in the whole dentate gyrus, a region occupied by EAAT2-expressing 
astrocytes and NSPCs. We also looked at the expression in the subgranular zone, a region 
predominantly occupied by NSPCs.  
Previous work in the Kirby lab shows that EAAT1 and EAAT2 mRNA decline in the DG 
of the hippocampus beginning 1 day after KA injury. Preliminary data from my lab also shows 
that after 1D there is no reduction in the NSPCs expression between KA and Saline injected mice. 
Based on this data, We hypothesized that NSPCs won’t change in their expression of EAAT1 or 





Neurological disorders are a critical health care issue and are the world's largest cause of disability-
adjusted life years (DALYs), or years of healthy life lost to due to death or disability (Collins 
2017). Studies shows that NSPCs are promising for reducing  neurological disability, and thus 
have emerged as a potential therapeutic approach for neural repair (Casarosa et. al 2014).  
Adult stem cells including NSPCs reside in specialized anatomical locations known as 
niches (Zhao et al. 2018). The NSPCs are self renewing, multipotent cells and  have radial 
processes spanning the entire granule cell layer and ramifying in the inner molecular layer (Yao et 
al. 2012). The behavior and fate of stem cells are strongly influenced by their niche and in the adult 
brain, NSPCs are restricted only to certain brain regions (Zhao et al. 2018). Two major NSPC 
populations reside in the adult brain in the hippocampal DG and walls of the lateral ventricles. 
These NSPC populations undergo proliferation and generate new neurons which mature over 
several weeks in the DG and olfactory bulb respectively (Yao et al., 2012). 
 Neurogenesis can be affected by extrinsic stimuli like seizures, growth factors and 
neurotransmitters (Zhao et. al 2018) and intrinsic mechanisms including dysregulation in 
epigenetics and transcription factors (Johnson et. al 2009). These mechanism contributes to 
numerous diseases for instance pathological events like Traumatic Brain Injury(TBI) can alter the 
neuronal function and DG is vulnerable to these changes because the cells lose their ability to 
regulate neurogenesis (Ngwenya et. al 2018). The decrease in neurogenesis contributes to 
hippocampus dependent behavioral deficits, cognition and emotional decline often seen in 
neurological disorders like epilepsy and seizures (Braun et a. 2014).In my experiment, KA 
injections were used to  cause  seizures in mice. The change in the EAAT expression was looked 
at 1, 3 and 7 days post- injury.  Two specific cell types,  astrocytes and NSPCs, were looked at 
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following excitotoxicity as EAAT expression and glutamate transportation across synapse is 






















EAATs and their expression in the NSPCs 
To look at the EAAT expression in the NSPCs, Kirby Lab mined a publicly available single cell 
RNA sequencing dataset (Shin et al., 2015; GEO: GSE71485) for expression of EAAT genes in 
NSPCs. Of the five EAAT transcripts, EAAT1(slc1a3) and EAAT2 (slc1a2) were enriched in 
NSPCs relative to the whole DG tissue (Figure 1) . EAAT1 expression was particularly robust in 
the NSPCs.  
 
Figure 1. NSPCs express EAAT genes in vivo. Quantification of EAAT genes (slc1a3, 
slc1a2,slc1a1,slc1a6 and slc1a7) using RNA sequencing of  Nestin-CFP expressing DG NSPCs 






EAAT mRNA expression declines following KA  
Preliminary data from my lab also shows that following KA injury, EAAT expression declines in 
the whole DG tissue (Figure 2). It is unclear why EAAT1/ EAAT2 mRNA decline following 
injury. Since these transporters are expressed by NSPCs and astrocytes, it could be possible that 
one of these cell types, or both, is down regulating EAAT expression and my experiment aims to 
look at the expression of these cells following KA injury. 
 
Figure 2.EAAT1 and EAAT2  mRNA decline in the DG following KA injury. Mice were 
injected with Saline or KA (25 mg/kg), and the DG were isolated for qPCR 6 hours or 1,3,7 days 
later. EAAT1 and EAAT2 mRNA significantly declined 1 day after KA. The EAAT1 and 









EAAT1 and EAAT2 transcriptional reporter mice (Regan et al. 2007) were kindly gifted by Dr. 
Jeffrey Rothstein (Johns Hopkins University). Heterozygous EAAT1-Dsred mice and EAAT2-
GFP mice were crossed with C57BL/6 wild type mice from The Jackson Laboratory. We used the 
offspring of 8-10 weeks old of these breeders for experiments. The offspring were genotyped using 
GFP primers and Dsred  primers. The sequence of GFP and DsRed primers and their internal 
controls use are: 
                          GFP                                                                         dsRed                                      
eGFP301-F GTGCAGTGCTTCAGCCGCTA      dsRed904-F TCCAAGGTGTACGTGAAGCA 
eGFP614-R TCGATGTTGTGGCGGATC     dsRed1394-R TACTGCTCCACGATGGTGTAGT 
Internal Control:                                              Internal Control: 
Rosa24500 CAGGACAACGCCCACACA    IMR7338 CTAGGCCACAGAATTGAAAGATCT 
Rosa21360 CTGGCTTCTGAGGACCG       IMR7339 GTAGGTGGAAATTCTAGCATCATCC 
Both male and female Dsred + and GFP + mice were selected for the experiment. The mice were 
separated into three groups using litter, age and sex. The experiment was done with a total of three 
cohorts to investigate the change in the EAAT expression after KA injury with each group 
represented below; 
3D time point 3D KA 3D Saline 7D KA 7D Saline 
Dsred n=8 n=6 n=9 n=5 




Mice were intraperitoneally injected with KA (25 mg/kg) or saline. The mice were observed for 
average of 3 hrs and seizure activity was recorded. All mice elicited seizure activity. The mice 
were placed in the colony room for the next 24 hrs and the perfusions were done at 1D, 3D and 
7D post-injury. All procedures were conducted in accordance with the Guide for the Care and Use 
of Laboratory Animals published by the National Institutes of Health and approved by The Ohio 
State University Institutional Animal Care and Use Committee. 
Histology 
Mice were perfused with ice-cold phosphate buffered saline (PBS)and the brains were collected 
and stored in 4% paraformaldehyde (PFA) in 4°C to fix over night. The next day the brains were 
placed in 30% sucrose for at least 3 days . 40 um sections were obtained via microtome  and 
were stored in cryoprotectant at -40°C  until immunohistochemical (IHC) processing. A series of 
every twelfth section across the entire extent of the hippocampus was used for IHC. 
Immunohistochemistry 
The tissue collected through slicing was used in a 2-day IHC procedure. On the first day, sections 
were rinsed 3 * 5 mins in PBS. Sections were blocked using 0.1% normal donkey serum , 0.4 %  
Triton-X  and PBS solution for 30 mins. Sections were then incubated overnight at 4°C with 
primary antibodies diluted in blocking solution. The source and dilutions for primary antibodies 
were as follows for EAAT2-GFP sections: goat anti-GFP (1:1000; invitrogen) , mouse anti-GFAP 
(1:1000; invitrogen ), rat anti SOX2 (1:1000). The source and dilutions for primary antibodies 
were as follows for detecting EAAT1-dsRed: goat anti-Dsred(1:500; invitrogen), mouse anti-
GFAP (1:1000; invitrogen), rat anti SOX2 (1:1000; invitrogen). The next day the sections were 
rinsed 3 * 5 minutes in PBS and incubated with fluorophore-conjugated secondary antibodies, all 
raised in donkey, as follows: anti gt 488 (1:500, invitrogen), anti ms 647 (1:500, invitrogen), anti 
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rt 594 (1:500, invitrogen) ) in blocking solution. The sections were  incubated in the nuclear stain 
Hoechst (1:2000) in PBS for 10 mins followed by 3 * 5 mins rinses in PBS. Section were then 
mounted on glass slides and cover slipped with Prolong Gold Antifade mountant (Invitrogen). 
Microscopy 
 ll prepared slides were imaged using Zeiss apotome and Zen software. Z-stack images were 
obtained and the same exposure times were used across all subjects. . The sections were then 
analyzed using the software detailed below. 
Fluorescence Intensity analysis 
 The fluorescence intensity of GFP and DsRed in the DG and SGZ of the hippocampus was 
determined using the NIH image J software to look at the level of fluorescence intensity. The 
Region of interest (ROI) was drawn around the molecular layer surrounding the whole DG. The 
SGZ ROI was drawn between the granule cell layer and hilus using the freehand tool.  
 
The average pixel intensity was measured in the ROI to obtain mean fluorescence intensity and 
integrated density was measured to obtain the mean value of intensity with respect to area covered. 
The GFAP% area was calculated by applying a thresholding algorithm and measuring the 
thresholded GFAP+ area fraction. Different preset ImageJ algorithms were applied to EAAT1-
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dsRed and EAAT2-GFP mice, but all images that were directly compared were thresholded using 
the same algorithm.  
Statistical Analysis: 
The data were then analyzed normalized to Control (Saline) and ANOVA test was done. To check 
the significance, Fisher’s LSD post-hoc test was done with significance being p<0.05. The 
Statistics were run on 1, 3 and 7 Day post injury for both EAAT2-GFP and EAAT1-dsRed mice. 
The results were then shown using the graphs through GraphPad Prism software where one-way 















Figure 3. KA does not significantly increase astrogliosis 1 day post-injury. There is a trend 
towards increased GFAP %area in KA mice 1D post-injury, but this is not significant (p>0.1)  
 
Figure 4. KA does not significantly increase EAAT2 expression 3 or 7 days post-injury. Mean 








Figure 5. Representative images of KA and Saline injected mice 1D post-injury. GFAP, GFP, 
Hoechst staining to show the GFP and GFAP expression. Both the KA and Saline group shows 











My experiment focuses on studying the cell types that can contribute to the decline of 
EAAT expression following KA injury. To evaluate this expression, I used the transcriptional 
reporter mice. The pilot data indicated that KA does not significantly increase astrogliosis relative 
to Saline injected mice at 1D post injury (Figure 3). The pilot data also shows that the EAAT2 
expression does not significantly change relative to Saline after KA injury at 1D (Figure 4). The 
representative image of both KA and Saline injected mice at 1D shows similar expression post ID 
injury (Figure 5). Based on this initial pilot data indicating no astrogliosis or change in EAAT2 
expression response to KA, we decided to look at additional timepoints ( 3 and 7 days)  for EAAT 
expression.  
The EAAT1 driven expression was also evaluated using the dsred immunoreactivity in the 
EAAT1-dsRed mice. Both the KA and Saline injected mice shows similar expression at 3D and 
7D relative to Saline (Figure 6). The EAAT1- Dsred expression was quantified to measure the 
average pixel intensity or Mean FI and the integrated density in the DG. The results showed no 
change in expression at 3 or 7 days after injury relative to Saline in the DG (Figure 7). We also 
quantified the Mean FI and Integrated density in the subgranular zone and did not find any 
significant change in expression at 3 or 7 days after injury relative to Saline in the SGZ (Figure 8). 
We also looked at the GFAP% area for EAAT1 and found that the GFAP % area in the EAAT1-
dsRed KA mice trended towards increased astrogliosis at 3D (Figure 9), but did not reach 
significance. 
The EAAT2 GFAP% area was also quantified and we found that KA does not  significantly 
increase astrogliosis at 3 or 7 day post-injury (Figure 10). The representative images  of GFP and 
GFAP shows similar expression between Saline and KA injected mice (Figure 11). The EAAT2 
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expression was quantified using the Mean FI and Integrated density and we did not found any 
significant change between the saline injected mice and 3 or 7 D KA injected mice in the DG  
(Figure 12). We also did not found any significant change in EAAT2 expression at 3 or 7 days 
after injury relative to Saline in the SGZ (Figure 13).  
Overall, we did not detect a change in both EAAT1 and EAAT2 transcriptional reporter. 
The results indicated that KA and Saline group shows similar expression post 3 and 7D injury 


















EAAT1- driven DsRed Expression 
` 
Figure 6. Representative images of KA and Saline injected mice 7-D post-injury. GFAP and 
Dsred staining to show the Glast and GFAP expression. Both the KA and Saline group shows 







EAAT1- driven DsRed Expression 
 
Figure 7. KA does not significantly increase EAAT1 expression 3 or 7 days post-injury in the 
DG.A) Mean DsRed fluorescence intensity (FI) between saline and KA mice. B) Integrated 
intensity (ID) between saline and KA mice in the DG 
 
Figure 8. KA does not significantly increase EAAT1 expression 3 or 7 days post-injury in 
SGZ. A). Mean DsRed fluorescence intensity (FI) between saline and KA mice. B) Integrated 




KA does not significantly increase astrogliosis 3 and 7D post injury 
 
Figure 9.KA does not significantly increase astrogliosis 3 or 7 days post-injury.  GFAP % area 
in the EAAT1-dsRed KA mice trended towards increased astrogliosis at 3D but did not reach 
significance.  
EAAT2- driven GFP Expression 
 
Figure 10.KA does not significantly increase astrogliosis 3 or 7 days post-injury.  GFAP % 




EAAT2 driven GFP Expression 
 
Figure 11. Representative images of KA and Saline injected mice 3D post-injury. GFP and 
GFAP staining to show the GFP and GFAP expression. Both the KA and Saline group shows 







EAAT2 driven GFP Expression 
 
Figure 12. KA does not significantly increase EAAT2 expression 3 or 7 days post-injury in 
DG. A)Mean DsRed fluorescence intensity (FI) between saline and KA mice in the DG. B) 
Integrated intensity (ID) between saline and KA mice in the DG 
 
Figure 13. KA does not significantly increase EAAT2 expression 3 or 7 days post-injury in 
the SGZ. Mean DsRed fluorescence intensity (FI) between saline and KA mice in the SGZ. B) 





The thesis investigated the changes in glutamate transporter expression in hippocampal 
subregions following injury. Based on the preliminary data from Kirby Lab suggesting that there 
is no reduction in EAAT expression in NSPCs at 1D post-injury, we hypothesized that NSPCs 
won’t change in their expression of EAAT1 or EAAT2 after KA instead we predicted that 
astrocytes will reduce expression of EAAT1 and EAAT2. Results indicated that we did not detect 
changes in fluorescent reporter expression in the SGZ or whole DG driven by EAAT1 and EAAT2 
transcription. 
We found no significant change in EAAT reporter expression at 3 and 7 days after injury 
in the whole DG, suggesting that  unlike with qPCR there was no tissue-level change in EAAT 
transcription using the transcriptional reporters. Similarly, we found no significant differences 
between saline and KA mice in the reporter expression associated with EAAT2 and EAAT1 
transcription in the SGZ, a niche for NSPCs. 
Furthermore, reactive astrogliosis was not observed in either EAAT1-DsRed or EAAT2-
GFP mice, despite a non-significant trend toward astrogliosis in EAAT1-DsRed mice at 3D post 
injury. Lack of astrogliosis complicates the interpretation of the EAAT reporter data. In previous 
studies performed by my lab, we observed a robust injury response including upregulation of the 
cytokine TNFα and reactive astrogliosis 3D post injury. Lack of reactive gliosis in this study 
suggests that the injury may not have been robust enough to drive a change in EAAT expression.  
It is unclear from present study whether these cells types have significant role in the reduction of 
EAAT expression following the KA injury since the reactive gliosis and the transporter expression 
was not significant. There is currently no study in the literature that has examined the function of 
EAATs in NSPCs specifically or have looked at the EAAT expression in specific cell types like 
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NSPCs after injury. However, one study done on the human neocortex showed that following TBI, 
the EAAT2 expression decreased in the astrocytes (Frank et al. 2006). It is possible that the 
expression was similar in the DG, however our study did not detect it. 
 The qPCR data that showed the change in EAAT expression was done at a larger sample 
size. However, increasing the sample size in this case won’t be effective as we did not see a robust  
change in injury response, suggesting that the issue could be with the methodology. One reason 
could be the protein stability. Dsred degrades at a much slower rate than the GFP. The half life for 
dsRed is 8.1 days and 3.8 days for GFP ( Vladislav et al. 2003). This suggests that through the use 
of transcription reporter mice it is possible that we did not reach the protein degradation  point and 
thus could not detect the change in expression.  
For future studies, it will be interesting to look at additional time points. It will also be 
better to use a method  that truly isolates the cell populations for example Fluorescence activated 
cell sorting (FACS), to study the cell specific expression patterns. Furthermore, the analysis could 












We investigated the changes in EAAT expression in different cell types  following KA 
injury because it is important to understand what was driving the change at the tissue level. 
However, we did not detect a change in EAAT transcriptional activity after Kainic acid injury for 
the transcriptional reporter mice. Overall, the transcriptional reporter mice expressed the 
GLAST/Dsred and GLT-1/GFP expression. 3D post injury showed a trend towards increase 
astrogliosis but this was not significant. The % GFAP detected the area covered by the astrocytes 
post 1D, 3D and 7D. The % area measured did not show an increase in astrogliosis at 1,3 or 7D 
after KA. Lack of astrogliosis indicates that the injury may not have been robust enough to cause 
a change in EAAT expression. I expected the aim to enhance our understanding of glutamate 
transporters and the role of NSPCs and astrocytes in the transporter expression following injury. 
Future studies can enhance our understanding of the role of these cell types in regulating the 
glutamate expression more and could potentially help understand the mechanism of change in 
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